Powell Investment Advisors, LLC Xeris Biopharma Holdings, Inc. Transaction History
Powell Investment Advisors, LLC
- $210 Million
- Q4 2024
A detailed history of Powell Investment Advisors, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Powell Investment Advisors, LLC holds 25,000 shares of XERS stock, worth $89,500. This represents 0.04% of its overall portfolio holdings.
Number of Shares
25,000
Previous 50,610
50.6%
Holding current value
$89,500
Previous $144,000
41.67%
% of portfolio
0.04%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding XERS
# of Institutions
152Shares Held
60MCall Options Held
148KPut Options Held
45.7K-
Black Rock Inc. New York, NY10.3MShares$37 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$28.3 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$18.3 Million62.59% of portfolio
-
Geode Capital Management, LLC Boston, MA3.35MShares$12 Million0.0% of portfolio
-
State Street Corp Boston, MA3.2MShares$11.5 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $487M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...